Martini, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 12.712
EU - Europa 10.267
AS - Asia 8.666
SA - Sud America 1.739
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 19
Totale 33.678
Nazione #
US - Stati Uniti d'America 12.421
SG - Singapore 4.049
DE - Germania 3.490
CN - Cina 2.106
SE - Svezia 1.572
BR - Brasile 1.431
IT - Italia 1.025
PL - Polonia 882
VN - Vietnam 823
FR - Francia 733
UA - Ucraina 698
GB - Regno Unito 454
IE - Irlanda 417
IN - India 366
FI - Finlandia 358
ID - Indonesia 270
RU - Federazione Russa 207
JP - Giappone 189
TR - Turchia 163
HK - Hong Kong 144
AR - Argentina 132
CA - Canada 132
BD - Bangladesh 105
MX - Messico 101
IQ - Iraq 89
NL - Olanda 71
AT - Austria 68
BE - Belgio 67
ZA - Sudafrica 65
CI - Costa d'Avorio 54
ES - Italia 51
VE - Venezuela 45
EC - Ecuador 42
PK - Pakistan 37
IR - Iran 30
SA - Arabia Saudita 30
KR - Corea 28
CH - Svizzera 26
KE - Kenya 25
LT - Lituania 25
CO - Colombia 24
JO - Giordania 22
MA - Marocco 21
PH - Filippine 21
UZ - Uzbekistan 20
CZ - Repubblica Ceca 19
PY - Paraguay 19
IL - Israele 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 16
CL - Cile 15
NP - Nepal 15
JM - Giamaica 14
AU - Australia 13
EU - Europa 13
GR - Grecia 13
PE - Perù 13
DZ - Algeria 12
EG - Egitto 12
OM - Oman 12
RO - Romania 12
SN - Senegal 12
AL - Albania 10
KZ - Kazakistan 10
KG - Kirghizistan 9
PT - Portogallo 9
BO - Bolivia 8
CR - Costa Rica 8
LB - Libano 8
MD - Moldavia 8
UY - Uruguay 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
GE - Georgia 7
HU - Ungheria 7
LV - Lettonia 7
MY - Malesia 7
NO - Norvegia 7
TH - Thailandia 7
TW - Taiwan 7
PA - Panama 6
HN - Honduras 5
KW - Kuwait 5
NG - Nigeria 5
NI - Nicaragua 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
DO - Repubblica Dominicana 4
GA - Gabon 4
HR - Croazia 4
LK - Sri Lanka 4
AO - Angola 3
BW - Botswana 3
DK - Danimarca 3
EE - Estonia 3
Totale 33.617
Città #
Singapore 2.264
Ashburn 1.722
Chandler 1.618
San Jose 1.029
Warsaw 843
Beijing 435
Jacksonville 421
Dublin 410
San Mateo 343
Nanjing 312
Fairfield 306
Wilmington 290
Los Angeles 287
Ann Arbor 285
New York 282
Woodbridge 280
Houston 277
Ho Chi Minh City 272
Munich 245
Jakarta 241
Seattle 231
Lauterbourg 229
Hanoi 225
Nürnberg 218
Dearborn 190
Helsinki 178
Rome 177
Boston 170
The Dalles 167
Cattolica 165
Tokyo 158
Frankfurt am Main 149
Cambridge 146
Milan 141
São Paulo 135
Dallas 133
Redmond 131
Lawrence 130
Hong Kong 128
Izmir 118
Moscow 112
Nanchang 112
Council Bluffs 107
Bremen 105
Hefei 101
Chicago 98
Marseille 94
Princeton 91
Santa Clara 87
Buffalo 84
Redwood City 76
Hyderabad 75
Kunming 68
Paris 62
London 61
Brussels 60
Orem 60
Abidjan 54
Mountain View 52
Tianjin 50
Lancaster 49
Guangzhou 48
Norwalk 48
Shenyang 48
Phoenix 46
Rio de Janeiro 46
Boardman 44
Hebei 42
Montreal 42
Vienna 41
Brooklyn 40
Denver 40
Shanghai 40
Zhengzhou 40
Changsha 38
Chennai 38
Johannesburg 38
Hangzhou 37
Jiaxing 37
Stockholm 35
Atlanta 34
University Park 34
Belo Horizonte 33
Düsseldorf 33
Toronto 33
Baghdad 32
Leawood 31
Da Nang 29
Falls Church 29
Poplar 29
Haiphong 28
Amsterdam 27
Augusta 27
Jinan 26
Kraków 26
Seoul 25
Dhaka 24
Kent 24
Naples 24
Porto Alegre 23
Totale 18.498
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 400
Deregulated expression of the imprinted DLK1-DIO3 region in Glioblastoma Stem-like Cells: tumor suppressor role of lncRNA MEG3 383
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 372
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 346
Fanconi anemia gene variants in therapy-related myeloid neoplasms 322
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 306
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 303
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 301
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 294
Role of p16/INK4a in gastrointestinal stromal tumor progression 286
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 280
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 272
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 252
Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1 246
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 230
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 209
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 209
Von hippel-lindau disease and erythrocytosis 208
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 206
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 196
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 190
A Large Series of Hyalinizing Trabecular Tumors: Cytomorphology and Ancillary Techniques on Fine Needle Aspiration 189
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 185
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 184
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 182
Endothelial progenitor cells in HIV-positive patients: what are we talking about? 182
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 182
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 181
PDGFRA-mutant syndrome 181
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 178
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 178
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Brain invasion along perivascular spaces by glioma cells: Relationship with blood–brain barrier 175
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 172
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 172
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model. 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 169
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 168
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 167
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 166
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature 165
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 164
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 160
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 160
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 160
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 160
An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome 160
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people 159
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 159
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 158
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 157
Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms. 155
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 155
Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review 155
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 155
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 155
Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells 154
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 154
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 152
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model 152
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 151
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 151
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 151
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 149
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 149
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 148
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 148
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 147
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 147
Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours 145
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 143
Short Communication: Proangiogenic Hematopoietic Cells In Acute HIV Infection 143
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 142
The role of fine-needle aspiration in the thyroid nodules of elderly patients. 141
Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification 141
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 140
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 140
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 140
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 139
Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma' 139
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 138
Unusual focal keratin expression in plexiform angiomyxoid myofibroblastic tumor: A case report and review of the literature 138
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 137
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 137
Molecular Analysis in a Glioblastoma Cohort—Results of a Prospective Analysis 136
High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells 135
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 134
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 134
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 134
Methylation study of the Paris system for reporting urinary (TPS) categories 134
Targeting the mitogen-activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low-grade glioma cells 134
Totale 19.077
Categoria #
all - tutte 129.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 0 0 0 0 0 0 0 0 0 347 52
2021/20222.128 192 164 55 174 158 79 47 327 111 140 307 374
2022/20234.514 623 649 360 712 252 543 219 349 505 57 151 94
2023/20242.435 89 591 57 130 64 247 395 287 38 77 231 229
2024/20254.256 111 124 362 182 325 172 187 183 627 438 828 717
2025/202610.969 1.671 343 661 1.343 2.122 600 2.046 607 769 724 83 0
Totale 34.033